AllerPops Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$470K
- Investors
-
3
AllerPops General Information
Description
Producer of prebiotic lollipops intended to offer relief from seasonal and long-term allergic symptoms and respiratory tracts. The company's lollipops are a revolutionary, disruptive, and miraculous product for allergy relief that consists of all-natural food and drug administration-approved food ingredients and treats the cause of allergies instead of symptoms alongside providing allergy relief that lasts for months to years, instead of mere hours, enabling consumers to ease respiratory upsets and irritations.
Contact Information
Website
www.allerpops.comCorporate Office
- 1650 Trinity Drive
- Suite 103
- Los Alamos, NM 87544
- United States
Corporate Office
- 1650 Trinity Drive
- Suite 103
- Los Alamos, NM 87544
- United States
AllerPops Timeline
AllerPops Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Equity Crowdfunding | 01-Aug-2023 | $470K | 00.000 | Completed | Generating Revenue | |
4. Grant | 11-Apr-2022 | 0000 | 00.000 | Completed | Generating Revenue | |
3. Seed Round | 00000 | 00.000 | Completed | Clinical Trials - General | ||
2. Seed Round | 28-Sep-2021 | $50K | $309K | Completed | Clinical Trials - General | |
1. Equity Crowdfunding | 01-May-2021 | $259K | $259K | Completed | Clinical Trials - General |
AllerPops Patents
AllerPops Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190343899-A1 | Oral microbiota transformation for the relief of immune system associated inflammations | Active | 15-Sep-2017 | 0000000000 | |
US-11083759-B2 | Oral microbiota transformation for the relief of immune system associated inflammations | Active | 15-Sep-2017 | 0000000000 | 0 |
US-10471033-B2 | Oral microbiota promotion for immune system associated inflammations | Active | 15-Sep-2017 | 0000000000 | 00 |
US-20190083435-A1 | Oral microbiota promotion for immune system associated inflammations | Active | 15-Sep-2017 | 0000000000 | |
US-20190343900-A1 | Oral microbiota composition for oral and/or sinus infections | Active | 24-Apr-2017 | A61K31/198 |
AllerPops Executive Team (3)
Name | Title | Board Seat |
---|---|---|
Cliff Han Ph.D | Founder & Chief Executive Officer | |
Amanda Giannini | Chief Financial Officer | |
Paul Scott | Chief Marketing Officer |
AllerPops Signals
AllerPops Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
New Mexico Economic Development Department | Government | 000 0000 | 000000 0 | |
Digital Wellness Technology | Venture Capital | Minority | 000 0000 | 000000 0 |
Moneyus Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
AllerPops FAQs
-
When was AllerPops founded?
AllerPops was founded in 2016.
-
Who is the founder of AllerPops?
Cliff Han Ph.D is the founder of AllerPops.
-
Who is the CEO of AllerPops?
Cliff Han Ph.D is the CEO of AllerPops.
-
Where is AllerPops headquartered?
AllerPops is headquartered in Los Alamos, NM.
-
What is the size of AllerPops?
AllerPops has 3 total employees.
-
What industry is AllerPops in?
AllerPops’s primary industry is Other Consumer Non-Durables.
-
Is AllerPops a private or public company?
AllerPops is a Private company.
-
What is AllerPops’s current revenue?
The current revenue for AllerPops is 00000.
-
How much funding has AllerPops raised over time?
AllerPops has raised $1.52M.
-
Who are AllerPops’s investors?
New Mexico Economic Development Department, Digital Wellness Technology, and Moneyus Capital have invested in AllerPops.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »